Collplant Biotechnologies Ltd
Veridion Score
Composite trend over time
Why is CLGN moving today?
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.
Real vendor fields plus Veridion-computed history. Missing fields stay blank.
Warehouse intelligence for CLGN.
CLGN insider activity
Collplant Biotechnologies Ltd
No multi-insider buying cluster in the last 90 days
Mixed: $0 across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for CLGN.
CLGN contract awards, year to date.
Public federal awards linked to this ticker.
CLGN lobbying filings, year to date.
Registered lobbying filings matched to Collplant Biotechnologies Ltd.